Overview

Assessment of the Therapeutic Utility of hMG-HP

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
To assess the effectiveness of a protocol of ovarian hyperstimulation with urinary gonadotrophins, to achieve clinical pregnancy in females undergoing IVF. Study hypothesis: to assess the effectiveness of a protocol of urinary gonadotrophins
Details
Lead Sponsor:
Ferring Pharmaceuticals
Collaborator:
Ferring SAU